newsfilter
← Latest News
GlobeNewswire·

Avalo Therapeutics Appoints Kevin R. Lind to Board of Directors

WAYNE, Pa., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (NASDAQ:AVTX), a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory